Syra Health to Participate in the Lytham Partners Fall 2023 Investor Conference

CARMEL, Ind., Oct. 10, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it will be participating in the Lytham Partners Fall 2023 Investor Conference taking place virtually on Tuesday, October 17, 2023. 

Company Webcast

The Company's webcast presentation will be available for viewing at 7:00 a.m. ET on Tuesday, October 17, 2023, on the Company's website at https://ir.syrahealth.com/ or https://wsw.com/webcast/lytham9/syra/2066136. The webcast will also be archived and available for replay.

Participation in Panel Presentation

Deepika Vuppalanchi, PhD, CEO, will be participating in a panel presentation titled, "Innovating Healthcare: Services and Solutions in the Modern Marketplace," which will take place on Tuesday, October 17, 2023, at 10:30 a.m ET. To access the panel, please visit: https://wsw.com/webcast/lytham9/panel4/2275744.

1x1 Meetings

Syra Health Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at [email protected] or register at https://lythampartners.com/fall2023invreg/.

ABOUT SYRA HEALTH CORP.

Syra Health is a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions. Syra Health aims to achieve its goal by becoming a valuable partner to government, payers, providers, life sciences organizations, and academic institutions. Syra Health offers products and services in digital health, behavioral and mental health, population health management, health education, and healthcare workforce. For more information, please visit www.syrahealth.com.

SAFE HARBOR STATEMENT

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors discussed in the "Risk Factors" section of the prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health Corp.
463-345-5180
[email protected] 

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
[email protected] 

SOURCE Syra Health Corp.